-
WHO rejects SII’s proposal seeking extension of Covishield’s shelf life from 6 to 9 months
The move comes even as India's drug regulator has extended Covishield's shelf life from six to nine months from its manufacturing date
-
Require around Rs 3,000 crore to ramp up vaccine production: SII CEO Adar Poonawalla
We need roughly Rs 3,000 crores which is not a small figure considering we have already spent thousands of crores, says Adar Poonawalla
-
Expiry date of Covishield extended to nine months
New Delhi: India’s drug regulator DCGI has extended the shelf life of Covishield, the Oxford-AstraZeneca COVID-19 vaccine, from six to nine mont
-
India’s daily COVID-19 cases cross 50,000 on lockdown anniversary
India's known coronavirus cases are approaching 12 million, with more than 160,000 deaths
-
Serum Institute of India seeks Centre’s nod to supply 50 lakh Covishield doses to UK
Serum Institute of India assured the Centre that its own anti-coronavirus vaccination programme will not be disturbed because of this supply
